Privacy, Personalization and Precision Health: Interview with DEPH Labs CEO Lisa Loud
AI is being applied to highly personal biological information, raising difficult questions about privacy and ownership .
Lisa Loud, CEO of DEPH Labs, discusses the complexities of AI in healthcare and the importance of data privacy in an interview with Olayimika Oyebanji. Great technology does not automatically lead to adoption, a lesson Lisa learned from her previous experience in PayPal, crypto, and other industries. She emphasizes the need for AI to improve healthcare today by interpreting complex biological information without overwhelming individuals.
However, she warns against underestimating the importance of privacy and infrastructure to keep sensitive data secure. Fragmented health data across various sources creates difficulties for consumers, researchers, and companies attempting to develop personalized health products. Lisa believes that bringing all health data under individual control could yield a more comprehensive picture of a person's health, without compromising privacy.
Longevity, biological age, and personalized health are attracting significant attention and investment. Lisa is cautiously optimistic about developments in these areas, preferring to focus on advancements that offer genuine utility instead of hype-driven claims. Her interest in DEPH stems from her desire to harness her expertise in consumer technology, fintech, and decentralized systems to address the challenges of privacy, ownership, and usability in precision health and biological data.
Written by urgent.news from HackerNoon's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
